These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18299517)

  • 1. Let all DNA vote: who are the amyotrophic lateral sclerosis candidates?
    Burghes AH; Butchbach ME
    Neurology; 2008 Feb; 70(9):662-3. PubMed ID: 18299517
    [No Abstract]   [Full Text] [Related]  

  • 2. Motoneuron-specific NR3B gene: no association with ALS and evidence for a common null allele.
    Niemann S; Landers JE; Churchill MJ; Hosler B; Sapp P; Speed WC; Lahn BT; Kidd KK; Brown RH; Hayashi Y
    Neurology; 2008 Feb; 70(9):666-76. PubMed ID: 17687115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [AMPA receptor-mediated neuronal death and amyotrophic lateral sclerosis].
    Hideyama T; Kawahara Y; Kwak S
    No To Shinkei; 2005 Jul; 57(7):585-98. PubMed ID: 16095220
    [No Abstract]   [Full Text] [Related]  

  • 4. [The role of genetics in amyotrophic lateral sclerosis].
    Weber M
    Praxis (Bern 1994); 2004 Feb; 93(8):275-9. PubMed ID: 15032138
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary lateral sclerosis as a phenotypic manifestation of familial ALS.
    Brugman F; Wokke JH; Vianney de Jong JM; Franssen H; Faber CG; Van den Berg LH
    Neurology; 2005 May; 64(10):1778-9. PubMed ID: 15911810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A4V superoxide dismutase mutation in apparently sporadic ALS resembling neuralgic amyotrophy.
    Weiss MD; Ravits JM; Schuman N; Carter GT
    Amyotroph Lateral Scler; 2006 Mar; 7(1):61-3. PubMed ID: 16546761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial amyotrophic lateral sclerosis (FALS): Emerging hints from redox proteomics. Highlight commentary on: "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis".
    Dalle-Donne I
    Free Radic Biol Med; 2007 Jul; 43(2):157-9. PubMed ID: 17603924
    [No Abstract]   [Full Text] [Related]  

  • 8. Motor Neuron Disease: New insights into genetic risk factors for amyotrophic lateral sclerosis.
    Malkki H
    Nat Rev Neurol; 2016 Sep; 12(9):491. PubMed ID: 27492589
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurochemistry of SOD1 and familial amyotrophic lateral sclerosis.
    Carrì MT; Ceroni M; Ferri A; Gabbianelli R; Casciati A; Costa A
    Funct Neurol; 2001; 16(1):73-82. PubMed ID: 11396274
    [No Abstract]   [Full Text] [Related]  

  • 10. Age at onset in sod1-mediated amyotrophic lateral sclerosis shows familiality.
    Fogh I; Rijsdijk F; Andersen PM; Sham PC; Knight J; Neale B; McKenna-Yasek D; Silani V; Brown RH; Powell JF; Al-Chalabi A
    Neurogenetics; 2007 Aug; 8(3):235-6. PubMed ID: 17549529
    [No Abstract]   [Full Text] [Related]  

  • 11. Facial onset sensory motor neuronopathy (FOSMN) syndrome: an unusual amyotrophic lateral sclerosis phenotype?
    Vucic S
    J Neurol Neurosurg Psychiatry; 2014 Sep; 85(9):951. PubMed ID: 24643461
    [No Abstract]   [Full Text] [Related]  

  • 12. Good science shows the way. Highlight Commentary on "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis".
    Estévez AG
    Free Radic Biol Med; 2007 Jul; 43(2):163-4. PubMed ID: 17603926
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic analysis and SOD1 mutation screening in Iranian amyotrophic lateral sclerosis patients.
    Alavi A; Nafissi S; Rohani M; Zamani B; Sedighi B; Shamshiri H; Fan JB; Ronaghi M; Elahi E
    Neurobiol Aging; 2013 May; 34(5):1516.e1-8. PubMed ID: 23062701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Of mice, men and motor neurons.
    Newbery HJ; Abbott CM
    Trends Genet; 2001 Oct; 17(10):S2-6. PubMed ID: 11585669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Motor neuron disease].
    Niwa J; Sobue G
    Tanpakushitsu Kakusan Koso; 2004 May; 49(7 Suppl):1127-8. PubMed ID: 15168546
    [No Abstract]   [Full Text] [Related]  

  • 16. [Motor neuron disease up-to date].
    Yamamoto M; Ishigaki S; Katsuno M; Sobue G
    No To Shinkei; 2005 Apr; 57(4):273-83. PubMed ID: 15948399
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manganese-containing superoxide dismutase signal sequence polymorphism associated with sporadic motor neuron disease.
    Van Landeghem GF; Tabatabaie P; Beckman G; Beckman L; Andersen PM
    Eur J Neurol; 1999 Nov; 6(6):639-44. PubMed ID: 10529750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel D109Y mutation in Cu/Zn superoxide dismutase (sod1) gene associated with amyotrophic lateral sclerosis.
    Naini A; Mehrazin M; Lu J; Gordon P; Mitsumoto H
    J Neurol Sci; 2007 Mar; 254(1-2):17-21. PubMed ID: 17257622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alsin, the product of ALS2 gene, suppresses SOD1 mutant neurotoxicity through RhoGEF domain by interacting with SOD1 mutants.
    Kanekura K; Hashimoto Y; Niikura T; Aiso S; Matsuoka M; Nishimoto I
    J Biol Chem; 2004 Apr; 279(18):19247-56. PubMed ID: 14970233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.